Brief: PeptiDream to invest $10 mln in Kleo Pharmaceuticals
Nov 7(Reuters) - PeptiDream Inc 4587.T
* Says it plans to invest $10 million (about 1.1 billion
yen) in
U.S.-based firm Kleo Pharmaceuticals Inc.
* Payment date on Nov. 12
Source text in Japanese:http://bit.ly/2qxjK1C
Further company coverage: 4587.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: huafang.zhang.reuters.com@reuters.net))
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner